CIK 0001159036 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 1.4 B | 660.1 M |
| Net income (USD) | 316.9 M | 202.1 M |
| Diluted EPS (USD/shares) | 2.56 | 1.44 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-08 | 4 | FORM 4 | 2026-10-06 |
| 2026-10-08 | 4/A | FORM 4/A | 2026-05-05 |
| 2026-10-02 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-02 | 3 | FORM 3 | 2026-09-28 |
| 2026-10-02 | 4 | FORM 4 | 2026-10-01 |
| 2026-09-30 | 8-K | 8-K items 5.02 | 2026-09-28 |
| 2026-09-22 | 8-K | 8-K items 1.01,2.03,3.02,9.01 | 2026-09-22 |
| 2026-09-18 | 8-K | 8-K items 8.01,9.01 | 2026-09-17 |
| 2026-09-17 | 4 | FORM 4 | 2026-09-16 |
| 2026-09-16 | 144 | 144 | |
| 2026-09-16 | 8-K | 8-K items 8.01,9.01 | 2026-09-16 |
| 2026-09-11 | 4 | FORM 4 | 2026-09-09 |
| 2026-09-02 | 4 | FORM 4 | 2026-09-01 |
| 2026-08-21 | 3 | FORM 3 | 2026-08-14 |
| 2026-08-19 | 4 | FORM 4 | 2026-08-17 |
| 2026-08-18 | 8-K | 8-K items 5.02 | 2026-08-14 |
| 2026-08-17 | 144 | 144 | |
| 2026-08-11 | 144 | 144 | |
| 2026-08-11 | 4 | FORM 4 | 2026-08-10 |
| 2026-08-10 | 144 | 144 | |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-07-09 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-02 | 4 | FORM 4 | 2026-06-30 |
| 2026-07-02 | 4 | FORM 4 | 2026-07-01 |
Forms on file (last 1,000): 4 487, 8-K 179, 144 76, SC 13G/A 48, 10-Q 44, 3 30, DEFA14A 16, DEF 14A 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=HALO (0.002 USD), /gw/filings/filings?ticker=HALO&form=8-K, /gw/filings/facts?ticker=HALO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange